[96a5a0]: / output / chiaCancer / identified / NCT00576173_identified.json

Download this file

303 lines (303 with data), 13.0 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
{
"info": {
"nct_id": "NCT00576173",
"official_title": "An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer Patients",
"inclusion_criteria": "* Patients with a histologically, radiologically or haematologically confirmed malignancy whose pain is judged by the investigator to be caused by the malignancy\n* Patients must have been on a stable daily dose of weak opioids or strong opioids for at least 72 hours prior to the start the study and must remain at the same dosage for the duration of the study\n* Patients must have a VAS (Visual analog scale) >=40mm\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Patients who have taken either morphine with daily dose more than 120mg or Fentanyl with daily dose more than 50ug/hr\n* Patients with significant abnormalities in hepatic or renal function which would, in the opinion of the investigator, prevent the patients involvement in the study\n* Patients with significant clinical abnormalities in CNS, respiratory or cardiovascular function, which in the investigators judgement prevents participation in the study\n* Patients who have taken antidepressants or anti-epileptic drugs, sedative hypnotics, selective serotonin reuptake inhibitor, short-acting analgesics, topical medications and anesthetics and/or muscle relaxants when taking Tramadol/Acetaminophen",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients with a histologically, radiologically or haematologically confirmed malignancy whose pain is judged by the investigator to be caused by the malignancy",
"criterions": [
{
"exact_snippets": [
"histologically, radiologically or haematologically confirmed malignancy"
],
"criterion": "malignancy",
"requirement_type": "confirmation method",
"expected_value": [
"histologically",
"radiologically",
"haematologically"
]
},
{
"exact_snippets": [
"pain is judged by the investigator to be caused by the malignancy"
],
"criterion": "pain",
"requirement_type": "cause",
"expected_value": "malignancy"
}
]
},
{
"line": "* Patients must have been on a stable daily dose of weak opioids or strong opioids for at least 72 hours prior to the start the study and must remain at the same dosage for the duration of the study",
"criterions": [
{
"exact_snippets": [
"Patients must have been on a stable daily dose of weak opioids or strong opioids"
],
"criterion": "opioid use",
"requirement_type": "stability",
"expected_value": true
},
{
"exact_snippets": [
"at least 72 hours prior to the start the study"
],
"criterion": "opioid use",
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 72
}
]
}
},
{
"exact_snippets": [
"must remain at the same dosage for the duration of the study"
],
"criterion": "opioid dosage",
"requirement_type": "stability",
"expected_value": true
}
]
},
{
"line": "* Patients must have a VAS (Visual analog scale) >=40mm",
"criterions": [
{
"exact_snippets": [
"VAS (Visual analog scale) >=40mm"
],
"criterion": "VAS (Visual analog scale)",
"requirement_type": "value",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 40
}
]
}
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "healthy volunteers",
"requirement_type": "participation",
"expected_value": true
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": [
"minimum age of 18 Years"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18
}
}
]
}
],
"exclusion_lines": [
{
"line": "* Patients who have taken either morphine with daily dose more than 120mg or Fentanyl with daily dose more than 50ug/hr",
"criterions": [
{
"exact_snippets": [
"morphine",
"daily dose more than 120mg"
],
"criterion": "morphine",
"requirement_type": "daily dose",
"expected_value": {
"comparisons": [
{
"operator": ">",
"value": 120
}
]
}
},
{
"exact_snippets": [
"Fentanyl",
"daily dose more than 50ug/hr"
],
"criterion": "Fentanyl",
"requirement_type": "daily dose",
"expected_value": {
"comparisons": [
{
"operator": ">",
"value": 50
}
]
}
}
]
},
{
"line": "* Patients with significant clinical abnormalities in CNS, respiratory or cardiovascular function, which in the investigators judgement prevents participation in the study",
"criterions": [
{
"exact_snippets": [
"significant clinical abnormalities in CNS"
],
"criterion": "CNS function",
"requirement_type": "abnormality",
"expected_value": true
},
{
"exact_snippets": [
"significant clinical abnormalities in",
"respiratory"
],
"criterion": "respiratory function",
"requirement_type": "abnormality",
"expected_value": true
},
{
"exact_snippets": [
"significant clinical abnormalities in",
"cardiovascular"
],
"criterion": "cardiovascular function",
"requirement_type": "abnormality",
"expected_value": true
}
]
},
{
"line": "* Patients who have taken antidepressants or anti-epileptic drugs, sedative hypnotics, selective serotonin reuptake inhibitor, short-acting analgesics, topical medications and anesthetics and/or muscle relaxants when taking Tramadol/Acetaminophen",
"criterions": [
{
"exact_snippets": [
"Patients who have taken antidepressants"
],
"criterion": "antidepressants",
"requirement_type": "prior use",
"expected_value": true
},
{
"exact_snippets": [
"Patients who have taken",
"anti-epileptic drugs"
],
"criterion": "anti-epileptic drugs",
"requirement_type": "prior use",
"expected_value": true
},
{
"exact_snippets": [
"Patients who have taken",
"sedative hypnotics"
],
"criterion": "sedative hypnotics",
"requirement_type": "prior use",
"expected_value": true
},
{
"exact_snippets": [
"Patients who have taken",
"selective serotonin reuptake inhibitor"
],
"criterion": "selective serotonin reuptake inhibitor",
"requirement_type": "prior use",
"expected_value": true
},
{
"exact_snippets": [
"Patients who have taken",
"short-acting analgesics"
],
"criterion": "short-acting analgesics",
"requirement_type": "prior use",
"expected_value": true
},
{
"exact_snippets": [
"Patients who have taken",
"topical medications"
],
"criterion": "topical medications",
"requirement_type": "prior use",
"expected_value": true
},
{
"exact_snippets": [
"Patients who have taken",
"anesthetics"
],
"criterion": "anesthetics",
"requirement_type": "prior use",
"expected_value": true
},
{
"exact_snippets": [
"Patients who have taken",
"muscle relaxants"
],
"criterion": "muscle relaxants",
"requirement_type": "prior use",
"expected_value": true
},
{
"exact_snippets": [
"when taking Tramadol/Acetaminophen"
],
"criterion": "Tramadol/Acetaminophen",
"requirement_type": "concurrent use",
"expected_value": true
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [
{
"line": "* Patients with significant abnormalities in hepatic or renal function which would, in the opinion of the investigator, prevent the patients involvement in the study",
"criterions": [
{
"exact_snippets": [
"significant abnormalities in hepatic",
"prevent the patients involvement"
],
"criterion": "hepatic function",
"requirement_type": "abnormality",
"expected_value": true
},
{
"exact_snippets": [
"significant abnormalities in renal",
"prevent the patients involvement"
],
"criterion": "renal function",
"requirement_type": "abnormality",
"expected_value": true
}
]
}
],
"failed_miscellaneous": []
}